drugset / Trial / NCT07007546
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants
RandomizedParallel-groupOpen-labelTreatment
Summary
To main objective is to evaluate the safety, tolerability, and pharmacokinetic profile of single or multiple oral doses of ABSK061 mini-tablets and to evaluate the effect of soft food with ABSK061 mini-tablets on its pharmacokinetic profile in healthy adult participants
Timeline
- Start
- 2025-05-17
- Primary completion
- 2025-07-30
- Completion
- 2026-04-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABSK061 | Unknown | 1 mg | Oral |
| Subject | ABSK061 | Unknown | 5 mg | Oral |
| Subject | ABSK061 | Unknown | 10 mg | Oral |
| Subject | ABSK061 | Unknown | 35 mg | Oral |
Indications
No indication recorded.